ICMR Clinical Trial Meet 2026 Held: Integrative Medicine and Research Innovation

Experts noted that the study represents an important step toward generating scientific validation for traditional medicine systems and integrating them responsibly into mainstream healthcare practices.

The Indian Council of Medical Research (ICMR) successfully organised the "1st ICMR Annual Clinical Trial Meet 2026" on May 20, 2026, bringing together leading policymakers, researchers, clinicians, scientists and regulatory experts to discuss the future of clinical research and evidence-based integrative medicine in India.

Held under the theme "International Clinical Trials Day: Focus on Integrative Medicine Clinical Trials," the national-level event served as an important platform for deliberations on strengthening India's clinical trial ecosystem, enhancing ethical governance and promoting innovation-driven healthcare research.

The conference witnessed participation from experts representing diverse sectors including medical research institutions, healthcare organizations, academia, regulatory bodies and the pharmaceutical industry. Discussions focused on improving clinical research infrastructure, streamlining regulatory systems and promoting scientifically validated integrative healthcare solutions for emerging public health challenges.

The programme was attended by prominent dignitaries including Prof. (Dr.) V. K. Paul, Member of NITI Aayog; Director General, ICMR, Dr. Rajiv Bahl; and Secretary, Ministry of AYUSH, Vaidya Rajesh Kotecha, along with several senior healthcare professionals and scientific experts.

Addressing the gathering, the dignitaries emphasized the importance of building strong and ethically governed clinical research systems capable of generating reliable scientific evidence for improving healthcare outcomes in India. They highlighted the growing relevance of integrative medicine and the need to scientifically evaluate traditional healthcare practices using modern research methodologies.

One of the key highlights of the event was the presentation of findings from a major multicentric Phase III Randomized Controlled Trial jointly conducted by ICMR and the Central Council for Research in Ayurvedic Sciences (CCRAS) on Iron Deficiency Anaemia, which remains one of India's major public health concerns.

The study evaluated integrative treatment approaches involving Ayurvedic formulations for the management of moderate anaemia among women. Researchers compared the effectiveness of Punarnavadi Mandura alone and in combination with Drakshavaleha against conventional Iron Folic Acid supplementation.

Conducted among nearly 4,000 non-pregnant women aged between 18 and 49 years, the study assessed haemoglobin levels and clinical outcomes over a 90-day period. According to the findings presented during the conference, both Ayurvedic formulations demonstrated therapeutic outcomes comparable to standard iron-folic acid therapy, opening new possibilities for evidence-based integrative healthcare approaches.

Experts noted that the study represents an important step toward generating scientific validation for traditional medicine systems and integrating them responsibly into mainstream healthcare practices.

Another major development during the event was the launch of a comprehensive report titled "Advancing First-in-Human Phase 1 Clinical Trials in India: A Delphi Study on Regulatory Pathways and Opportunities."

The report was prepared through a structured two-round consultation process involving 37 experts from the pharmaceutical industry, academia, Contract Research Organisations (CROs) and national regulatory agencies. The study examined the current challenges faced in conducting early-phase clinical trials in India and identified several bottlenecks affecting innovation and drug development.

The report recommended measures such as strengthening regulatory infrastructure, simplifying approval mechanisms, improving inter-agency coordination and enhancing institutional capacity to support advanced clinical research and innovation-led pharmaceutical development in India.

Officials noted that strengthening India's capability in conducting first-in-human and early-phase clinical trials is critical for positioning the country as a global hub for biomedical research, drug innovation and advanced therapeutics.

The event also witnessed the release of the "Operational Guidelines for Single Ethics Review of Multicentre Research in India." These guidelines aim to harmonise and strengthen ethical review systems for multicentre research projects across the country while reducing duplication, improving efficiency and ensuring stronger participant protection standards.

Healthcare experts observed that standardized ethical review mechanisms are essential for improving the quality, transparency and speed of multicentre clinical studies in India's rapidly expanding medical research ecosystem.

A panel discussion on "Policy Uptake of Integrative Research Evidence" was also organised during the programme. The discussion focused on translating scientific research findings into public health policies and practical healthcare interventions. Experts discussed the importance of evidence generation, regulatory support and interdisciplinary collaboration in mainstreaming integrative healthcare solutions.

Participants also explored the role of emerging technologies, digital health systems, artificial intelligence and data-driven research methodologies in improving clinical trial efficiency, patient monitoring and healthcare innovation.

The Annual Clinical Trial Meet reaffirmed ICMR's commitment to strengthening India's research ecosystem through collaboration, scientific excellence, ethical governance and innovation. Experts believe that initiatives such as these are crucial for enhancing India's global standing in biomedical research and creating healthcare solutions tailored to the country's unique public health challenges.

The event also highlighted India's growing focus on combining modern medicine with scientifically validated traditional healthcare systems to create more accessible, affordable and holistic healthcare models for the future.